Cutaneous Manifestations of COVID-19 in the Inpatient Setting - 21/09/21

Doi : 10.1016/j.det.2021.05.011

Mytrang H. Do, PhD ^a,^{^{†
These authors contributed equally to this work.}}, Claire R. Stewart, BA ^a,^{^{†
These authors contributed equally to this work.}}, Joanna Harp, MD ^b,^⁎
^a Weill Cornell Medicine, New York, NY, USA
^b Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY, USA

^∗Corresponding author. Department of Dermatology, 1305 York Ave, 9th Fl, New York, NY 10021.Departmentof Dermatology1305 York Ave9th FlNew YorkNY10021

connectez-vous ou créez un compte

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Résumé

Cutaneous findings have increasingly been reported in patients with coronavirus disease 2019 (COVID-19). This review discusses associated skin findings in patients with COVID-19 in the inpatient setting, ranging from vasculopathy-related lesions associated with high hospitalization rate and poor prognosis to inflammatory vesicular and urticarial eruptions that are rarely associated with prolonged hospitalization. We also discuss other reported COVID-19 cutaneous manifestations such as Sweet's syndrome, purpuric eruptions, and Multisystem Inflammatory Syndrome in Children. Although the relationship between dermatologic changes and COVID-19 disease progression is not fully elucidated, familiarity with cutaneous manifestations is valuable for physicians caring for patients hospitalized with COVID-19 and may help improve disease recognition and care.

Le texte complet de cet article est disponible en PDF.

Keywords : COVID-19, Cutaneous, Inpatient, Vasculopathy, Viral exanthem, Complement, MIS-C